Cochrane Organisational Dashboard | Q1 (Jan-Mar) 2017
Cochrane Library Usage
Cochrane.org Quarterly Usage
5,000,0005
2,023,472
2,000,000
1,500,000
1,000,000
2,591,209
2,504,441
Page Views
3,453,936
2,500,000
2,973,501
3,000,000
1,060,814
1
108
Q1 2016
Q2 2016
Q3 2016
Q4 2016
Q1 2017
133
Protocols
Income and expenditure (YTD)
Actual expenditure
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Updates
3
Q1 2017
Royalties
Millions (£)
116
107
Reviews
2
1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
93
Q1 2016
Q1 2016
500,000
0
93
82
108
107
Q1 2016
1,402,428
1
Overview
3,173,422
3
4,234,236
4
Millions
• Cochrane Library use in Q1 shows a 35% year
Q12015
2015
Q12016
2016
Q12017
2017
Q1
Q1
Q1
on year increase in demand.
4,000,0004
• cochrane.org usage continues to soar. ↑ 71%
compared with Q1 2016.
3
• Royalties showing very strong growth (↑ 13%3,000,000
compared with Q1 2016). This is partly linked
2,000,0002
to changes in exchange rate.
• Cochrane Connect sign-ups have increased
1,000,0001
21% in Q1 compared with Q4 2016 (52%
increase from Q1 2016).
• Non-english usage of our website continues to 1 00
Abstracts
FTD
AccessDenied
Denied Demand
Demand
Abstracts
FTD
Access
grow with 68% of visitors in Q1 using nonEnglish browsers.
Targets for 2017
• We also now present data on the language of
• 8/10 Targets Green and on course
the pages visited and this shows around 56%
of page views are of translated content
• The Enhanced Cochrane Library continues to
demonstrating the value of our translation
be challenging and a publication date in 2017
initiatives.
is still not guaranteed.
• We can now track media uptake in all
• The RevMan Web target is likely to be delayed
languages, and we see a strong Q1 result of
due to competing requests for technical
2,203 media hits across all languages
resources from the Enhanced Library project
• Cochrane Crowd now has over 5,000 members
and the Membership project.
• Covidence usage growing quickly in Cochrane,
with a 206% increase in total users compared
with Q1 2016
Publishing Output
3,500,000
Q4 2015
Commentary & Achievements
Budgeted expenditure
Actual income
Budgeted income
£0.0
£0.5
£1.0
£1.5
£2.0
£2.5
£3.0
Millions
Reserves at end of Q1 2017
£5.44 million
13% ↑ (Q1 2017 vs Q1 2016)
5
4
Strategy to 2020 Targets for 2017
2017 Targets
PURPLE: not started or N/A; RED: serious concerns; AMBER: some delays; GREEN: on target
1. Complete the development of RevMan Web and
begin phased implementation for Cochrane
Reviews
10. Complete implementation of the approved
governance reforms
7. Host a successful Global Evidence Summit
60
50
2017 Reviews
40
2016 Reviews
Published Output
Quality
Reviews with Summary of Findings
(SoF) Tables
New
Reviews
84
84
67
New
New
Updates
Reviews
Reviews
With SOF
Output
Total records
2017 Protocols
2016 Protocols
Issue 1
Updates
Issue 2
Published output year to date (cumulative)
Without SOF
2016 Protocols
10%
2017 Protocols
WithoutSOF
SOF
Without
Without
SOF
2016 Updates
Q1 2016
2016
Q1
2017 Updates
SOFof new
Without SOF
As a comparison,With
70%
reviews published in 2015 had SoF
tables.
2016 Reviews
8
7
0
20
40
60
80
100
English
Non-EnglishEnglish
Access
Q1 2016
Geographic Reach
Q3 2016
Top 10 usage of cochrane.org website
36%
36%
(cochrane.org)
Non-English
Non-English
64%
64%
500000
32%
450000
400000
36%
64%
68%
350000
Q1 2017
300000
English
English
11
250000
150000
332
100000
50000
5
0
3,155
Twitter
LinkedIn
Q4 2016
12,442
Facebook
Q3 2016
3%
928,985 1,039,010
11%
0%
EED
17,397
17,397
0%
HTA
15,646
15,646
0%
111
119
7%
12
Access to Translated Content
50000
60000
50%
Reviews published as Gold Open Access in Q1 2017
45%
44%
56%
55%
56%
25%
Reviews in total available open access at end of Q1 2017
0%
Jan
344
Industry sponsorship and research outcome
281
Interventions to improve antibiotic prescribing practices for hospital
inpatients
2,203
1,147
Skin-to-skin care for procedural pain in neonates
128
118
Support for healthy breastfeeding mothers with healthy term babies
Webinars delivered
(Q1 2016: 1)
Webinar attendees
(Q1 2016: 37)
354
14,451
Views of recorded webinars
All webinar views cumulative
since launch in Q1 2016
pieces of global media
coverage in all languages
pieces of global media
coverage in English language
2
346
Global press releases
Workplace interventions for reducing sitting at work
Paracetamol for low back pain
Vitamin D for the management of asthma
attracted media hits
• Yoga treatment for chronic non-specific low-back pain; and
• Interventions to improve antibiotic prescribing practices for hospital
inpatients.
17
Active Contributors
Cochrane Learning Live
162
Mar
English content
(compared with 1,089 in Q1 2016)
Parents' and informal caregivers' views and experiences of
communication about routine childhood vaccination: a synthesis of
qualitative evidence
3
Feb
Translated content
Media Reach and Impact
16
15
44%
75%
Reviews made available as Green Open Access in Q1 2017
Q1 2016: 927
Q2 2016: 268
Q3 2016: 638
Q1 2016
Goal Four
2,543
1,405 new & updated translations published in 14 languages
16 podcasts translated & recorded in 7 languages
82 blog shots translated in 5 languages
By comparison, top scores in each quarter in 2016 were:
Q2 2016
40000
2,460
Translation Activity
542
Q1 2017
30000
Protocols
9
140
Yoga treatment for chronic non-specific low back pain
148
20000
6%
36,795
Altmetrics
4,857
10000
7,258
14
56,991
18
Q1 2016
Non-English
Non-English
120
13
Q12016
Social Media
0
6,822
36,795
100%
Q12017
Reviews
DARE
Open Access
200000
10
5%
Editorials
2017 Reviews
Change
9,791
CENTRAL
Issue 3
Q1 2017
9,282
CDSR Total
2016 Updates
20
0
45
45
26
Q1 2016
2017 Updates
30
10
90%
11%
With
SOF
With
With
SOF
SOF
Goal Two
9. Launch a Cochrane membership scheme
6. Complete the first-phase delivery of an enhanced
Cochrane Library in English and Spanish
3. Complete the delivery of a programme of training
and accreditation for editors
89%
Goal Three
8. Begin implementation of the approved Cochrane
Review Group transformation programme, and
finalize remaining proposals for organizational
Structure & Function reforms
5. Define an organization-wide framework for
knowledge translation activities
2. Complete the Transform project
6
Goal One
4. Improve the process of producing translations to
make it easier for Cochrane translators and editors
General interest: Cochrane Connect Subscribers
6500
RevMan (active authors)
5,060 ↑ 19%
Cochrane Crowd (total members)
5,198 ↑ 138%
TaskExchange (total users)
6000
5500
5000
4500
4000
910 ↑ 133%
3500
Covidence (total Cochrane users)
3000
1,704 ↑ 206%
19
2500
20
Q1 2014
Q3 2014
Q1 2015
Q3 2015
Q1 2016
Q3 2016
Q1 2017
Notes on the data
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Access denied means a user tried to download a full text, but did not have a subscription to the Cochrane
Library. Demand is the combination of successful full text downloads and attempted full text downloads
(access denied). Data is for Q1 for each of the years shown and excludes usage of Biblioteca Cochrane Plus.
This is a measure of sessions of the cochrane.org website
Compared with Q1 2016: Reviews: 7% ↑; Updates: 12% ↓; Protocols: 24% ↑.
13% increase is Q1 2017 compared with Q1 2016. Currency fluctuation has had a positive result on income.
The figures presented for income and expenditure are year to date i.e. January to March.
Most targets are on course with the exception of the Cochrane Library target which we have reported
separately as being red. The RevMan web target is delayed due to resources being spent on the Cochrane
Library project and membership.
These data are based on all reviews and updates published in Q1 2016.
Cumulative year to date compared with previous year: Reviews: 7% ↑; Updates: 12% ↓; Protocols: 24% ↑.
DARE and EED are no longer being updated.
The bar chart provides data for the top ten countries.
The English / non-English split is based on the user’s browser language.
This is all activity in Q1 2017. Review translations are PLS and/or Abstract, not whole reviews.
Green open access (OA) means reviews are made available after a 12 months embargo, Gold OA means
reviews are available immediately. For details see: http://www.cochranelibrary.com/help/open-accessoptions-for-the-cochrane-library.html
14.
15.
16.
17.
This data is based on the language of the web page, so shows the usage of our translated content.
The graph shows Twitter “followers”; LinkedIn “group members”; Facebook “group members”.
Scores shown are the Altimetric scores for reviews published in the previous quarter.
As of Q1 2017 we have a new media tracking service that can track media uptake across all languages.
However, we only have comparative data for English language media hits as our media service used in
2016 only tracked English language media hits.
18. These are webinars delivered as part of Cochrane Learning Live. We do not have quarter by quarter data
for webinar views in 2016, so there is no directly comparative data currently. The cumulative count of
views is for all webinars in the series, some of which have had over a year to build up their view count. The
top webinar is an introduction to Covidence at over 8000 views, and the second most watched is a webinar
on use of GradePro GDT in Cochrane reviews at around 4000 views.
19. Percentage increase is comparison with Q1 2016. RevMan (active authors) 5,060 (4,244 Q1 2016); Cochrane
Crowd (total members) 5,198 (2,187 Q1 2016); TaskExchange (total users) 910 (391 Q1 2016); Covidence
(total Cochrane users) 1,704 (556 Q1 2016)
20. As part of the implementation of Cochrane membership we should see an increase in subscribers to
Cochrane Connect as a proxy for interested people engaging with Cochrane. In Dec 2016 we introduced
some design improvements to make Cochrane Connect sign up more visible.